Description
Product details
Rosufree F 5 Rosuvastatin + Fenofibrate Tablets Rosufree F 5 is a combination lipid-lowering medicine containing Rosuvastatin and Fenofibrate. It may be prescribed for selected patients with mixed dyslipidemia, where management of LDL cholesterol and triglycerides is required. Mechanism : Rosuvastatin Pathway HMG-CoA reductase blocked → liver cholesterol production decreases → LDL receptors increase → more LDL is removed from blood Fenofibrate Pathway PPAR-α activated → triglyceride metabolism increases → triglyceride-rich particles decrease → lipid profile can improve Why Rosufree F May Be Important In appropriately selected patients, controlling mixed dyslipidemia can form part of a broader strategy to reduce atherosclerotic cardiovascular risk. The combination may be considered when lifestyle measures and individual lipid-lowering treatment do not adequately address the patient's lipid pattern, particularly when triglycerides remain an important concern. Treatment should still be accompanied by appropriate: Diet modification Regular physical activity Weight management where appropriate Diabetes control where relevant Smoking cessation Management of other cardiovascular risk factors Side Effects Because Rosufree F contains two lipid-modifying medicines, adverse effects from both components need consideration. Possible Effects Headache Nausea Abdominal discomfort Constipation Muscle aches Weakness Changes in liver enzymes Fenofibrate may also be associated with gastrointestinal symptoms and gallstone-related problems in susceptible patients. Storage & Handling For appropriate product care: Keep Rosufree F 5 in its original blister and carton. Follow the storage temperature stated on the marketed product pack. Protect tablets from excessive heat and moisture. Keep the blister dry and undamaged. Handle tablets with clean, dry hands. Do not use medicine after the printed expiry date. Avoid using tablets from damaged packaging if product integrity is uncertain. Keep out of reach and sight of children. Do not transfer tablets into an unidentified container for prolonged storage. Frequently Asked Questions 1. What is Rosufree F 5 used for? It may be prescribed for selected patients with mixed lipid abnormalities where management of both cholesterol and triglycerides is clinically required. 2. Why are Rosuvastatin and Fenofibrate combined? Rosuvastatin primarily reduces LDL cholesterol, while Fenofibrate has a significant triglyceride-lowering effect. 3. How does Fenofibrate work? Fenofibrate activates PPAR-alpha, influencing lipid metabolism and increasing the breakdown of triglyceride-rich particles. 4. Why is muscle pain important with Rosufree F? Both statins and fibrates can cause muscle-related adverse effects. Persistent or unexplained muscle symptoms should be medically assessed. 5. Does Rosufree F require kidney monitoring? Kidney function can be particularly important for determining the safety and suitability of Fenofibrate therapy. 6. Can Rosufree F affect the liver? Yes. Both components can influence liver-related laboratory parameters, so liver assessment may be appropriate.
